This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Immunomedics Inc
IMMU : NASDAQ : Health Care
$3.44 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 774,300
07/24/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
IMMU IMMUNOMEDICS INC 3.15 291.30 n/m 9.22 101.92
ZIOP ZIOPHARM ONCOLOGY INC 3.22 324.34 n/m 0.80 0.00
PGNX PROGENICS PHARMACEUTICAL INC 4.50 313.00 n/m 7.45 -46.97
PPHM PEREGRINE PHARMACEUTICLS INC 1.62 309.03 n/m 22.40 3.31
GALE GALENA BIOPHARMA INC 2.58 304.51 n/m 4.66 n/a
SVA SINOVAC BIOTECH LTD 5.44 302.30 34.00 76.02 42.63
RGLS REGULUS THERAPEUTICS INC 6.60 286.16 n/m 17.96 93.45
CUR NEURALSTEM INC 3.14 272.43 n/m 0.01 -96.91
RIGL RIGEL PHARMACEUTICALS INC 3.04 266.09 n/m 7.15 376.66
FOLD AMICUS THERAPEUTICS INC 3.76 241.92 n/m 0.82 -92.31
CCXI CHEMOCENTRYX INC 5.56 240.48 n/m 4.13 -34.69
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

IMMU Ind Avg S&P 500
n/m 52.05 19.42

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs